Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8305 - 8312 of 12008 results
Innocents Abroad: Sending Employees Into Harm’s Way – A Word About Offer Letters Part 2
April 6, 2016| Blog| Viewpoint
Senate HELP Committee Convenes Third and Final Cures Markup
April 6, 2016| Advisory| Viewpoint
Oil, Gas and Mineral Companies Take Note: Agreements Purporting to “Run with the Land” may be Rejected in Bankruptcy
April 6, 2016| Blog| Viewpoint
U.S. and China Pledge to Sign Paris Climate Accord on April 22
April 5, 2016| Blog| Viewpoint
Equal Pay for Equal Play – U.S. Women’s National Team Files Wage Discrimination Claim Against U.S. Soccer
April 5, 2016| Blog| Viewpoint
Co-Author, Supreme Court Left Unresolved Questions in Tyson Decision
April 5, 2016| News
E2 Report Finds Clean Energy Employs 2.5 Million Americans
April 4, 2016| Blog| Viewpoint
Corporate Divorce Series: Online Dating, The Bachelor, and Predicting Successful Employment Relationships
April 4, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|